Author:
Ciaccio Marcello,Lo Sasso Bruna,Milano Salvatore,Gambino Caterina Maria
Publisher
Springer International Publishing
Reference12 articles.
1. Atzeni F, Sebastiani M, Ricci C, Celano A, Gremese E, Iannone F, Meroni PL, Minghetti P, Sarzi-Puttini P, Ferraccioli G, Lapadula G (2015) Position paper of Italian rheumatologists on the use of biosimilar drugs. Clin Exp Rheumatol 33:1–4
2. Ford AC, Sandborn WJ, Khan KJ et al (2011) Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol 106:644–659
3. Ha C, Mathur J, Kornbluth A (2015) Anti-TNF levels anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 9:497–505
4. Knight DM, Trinh H, Le J et al (1993) Construction and initial characterization of a mouse-human anti TNF antibody. Mol Immunol 30:1443–1453
5. Mav W, Murray DL, Snyder MR (2015) Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases. Transl Res 165:270–282